Hepion Pharma Raises $3.055M in Private Placement

Hepion Pharmaceuticals, Inc. entered into securities purchase agreements with accredited investors for a private placement offering. The company issued an aggregate of 61,100,000 shares of common stock and warrants to purchase an equal number of shares, generating gross proceeds of $3,055,000. The offering price was $0.05 per share, with warrants exercisable at $0.06 per share for five years. The transaction closed on August 3, 2026.